The first Oncocyte trade was made in Q1 2019.
Since then Jim Simons bought shares six more times and sold shares on seven occasions. The investor sold all their shares in Q3 2023 and doesn't own any shares in Oncocyte anymore.
Avg closing price
Price range
Sold -6.91k shares
Q3 2023
Avg closing price
$3.72
Price range
$3.12
-
$4.59
Increased shares by 131.7% (+3.93k shares)
Q2 2023
Avg closing price
$5.04
Price range
$4.00
-
$7.00
Increased shares by 111.3% (+1.57k shares)
Q1 2023
Avg closing price
$7.42
Price range
$4.00
-
$9.76
New holding (+1.41k shares)
Q4 2022
Avg closing price
$11.02
Price range
$5.08
-
$15.60
Sold -7.87k shares
Q2 2022
Avg closing price
$22.74
Price range
$17.20
-
$30.60
Sold 6.2% shares (-522 shares)
Q1 2022
Avg closing price
$31.97
Price range
$23.00
-
$45.00
Increased shares by 195.1% (+5.55k shares)
Q4 2021